ONCOGENEX TECHNOLOGIES INC. 4,500,000 Common Shares UNDERWRITING AGREEMENT Dated: •, 2007Underwriting Agreement • February 23rd, 2007 • Oncogenex Technologies Inc • Pharmaceutical preparations • New York
The undersigned, a shareholder, option holder and/or an officer and/or director of OncoGenex Technologies Inc. (the “Company”) understands that RBC Dominion Securities Inc., RBC Capital Markets Corporation and such other financial institutions as may agree to become underwriters (collectively, the “Underwriters” and each an “Underwriter”) propose to enter into an underwriting or agency agreement (the “Underwriting Agreement”) with the Company, pursuant to which the Company will complete a public offering in Canada and the United States of common shares of its capital stock (the “Common Shares” and such offering the “Offering”).
